1103284

GlaxoSmithKline LLC — FEI 1035048

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 12, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Durham, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)